Research Article
Candida Bloodstream Infection: Changing Pattern of Occurrence and Antifungal Susceptibility over 10 Years in a Tertiary Care Saudi Hospital
Table 4
Candida species susceptibility profile.
| | Candida spp | Amphotericin B N (%) | Caspofungin N (%) | Fluconazole N (%) | Voriconazole N (%) |
| | C. albicans | 106 (98.1) | 106 (98.1) | 83 (76.9) | 89 (82.4) | | C. tropicalis | 72 (100) | 69 (95.8) | 52 (72.2) | 63 (87.5) | | C. glabrata | 60 (100) | 58 (96.7) | 29 (48.3) | 47 (78.3) | | C. parapsilosis | 52 (100) | 52 (100) | 32 (61.5) | 51 (98) | | C. krusei | 13 (76.5) | 16 (94) | 4 (23.5) | 16 (94) | | Others | 12 (80) | 13 (86.7) | 14 (93.3) | 15 (100) |
|
|
